HomeADXS • OTCMKTS
Follow
Ayala Pharmaceuticals Inc
Previous close
$0.60
Day range
$0.64 - $0.65
Year range
$0.51 - $1.95
Market cap
27.57M USD
Avg Volume
7.72K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.13M | -29.26% |
Net income | -7.34M | 27.94% |
Net profit margin | — | — |
Earnings per share | -1.53 | — |
EBITDA | -7.08M | 29.45% |
Effective tax rate | -0.89% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.12M | — |
Total assets | 6.98M | — |
Total liabilities | 13.22M | — |
Total equity | -6.24M | — |
Shares outstanding | 10.75M | — |
Price to book | -0.46 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -7.34M | 27.94% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Headquarters
Website
Employees
14